Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-02-16

Clinical Trial Update: Detection of False Positives From First-trimester Preeclampsia Screening (StopPRE) at the Second-trimester of Pregnancy [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating false-positive detection from first-trimester preeclampsia screening when applied at the second trimester.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Hospital Universitari Vall d'Hebron Research Institute | Conditions: Pre-Eclampsia | Phase 3 | Status: COMPLETED